BMEZ / BMEZ: Buy Low, Hold For The Distribution And Rebound

We review CEF market valuation and performance through the third week of October and highlight recent market action. All CEF sector NAVs were down on more_horizontal

BlackRock Health Sciences Term Trust announced a distribution cut, and this unique CEF now trades at an unusually large discount to NAV. With inceptio more_horizontal

This month I added to three of my already existing positions to grow my income. I'm continuing to avoid adding too much in terms of leveraged funds to more_horizontal

BlackRock Health Sciences Term Trust is an actively managed fund specializing in healthcare and medicine, with a dividend yield of 10% largely due to more_horizontal

BMEZ's portfolio has a combination of unknown small-cap "next generation" healthcare holdings and some familiar names in the field of biotechnology. L more_horizontal

The BMEZ fund combines investments in 'next generation' healthcare stocks with pre-IPO private investments. The fund also pays a high current distribu more_horizontal

BMEZ has been getting hit significantly, with the biotech and growth space moving sharply lower. Despite these pressures, I believe that BMEZ is attra more_horizontal

BMEZ was one of the best performing funds in 2020, the year it launched as it hit the market at the right time. more_horizontal